Japan vs Slovakia: Cause of death, by non-communicable diseases, ages 5-14, male
Japan
59.6%
in 2021
Slovakia
59.3%
in 2021
Japan rank
26th
Slovakia rank
29th
Cause of death, by non-communicable diseases, ages 5-14, male over time
- Japan
- Slovakia
How they compare
Japan currently reports 59.6% against 59.3% in Slovakia, a difference of 0.3%.
The two have swapped places 2 times across 6 shared years of data; in 2000 it was Japan ahead.
Japan ranks 26th and Slovakia ranks 29th of 185 countries.
Across the 3 decades both report, Japan averaged higher in 2 and Slovakia in 1.
Head to head by decade
| Decade | Japan | Slovakia | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 49.6% | 38.5% | 11.1% | Japan |
| 2010s | 54.1% | 56.6% | 2.5% | Slovakia |
| 2020s | 57.3% | 54.3% | 3.0% | Japan |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher cause of death, by non-communicable diseases, ages 5-14, male, Japan or Slovakia?
- Japan, at 59.6% against 59.3% in Slovakia as of 2021.
- What is the difference in cause of death, by non-communicable diseases, ages 5-14, male between Japan and Slovakia?
- 0.3%, with Japan ahead.
- How many years of comparable data are there for Japan and Slovakia?
- 6 years are reported by both, from 2000 to 2021.
- How do Japan and Slovakia rank globally for cause of death, by non-communicable diseases, ages 5-14, male?
- Japan ranks 26th and Slovakia ranks 29th of 185 countries.
- Where does this data come from?
- Global Health Estimates, World Health Organization (WHO), published as Cause of death, by non-communicable diseases, ages 5-14, male (% of total male deaths ages 5-14). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of male deaths ages 5-14 due to non-communicable diseases divided by number of all male deaths ages 5-14, expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.